baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out VRTX/ DE000UK2V6K0 /

20/09/2024 19:27:20	Chg.-0.110	Bid21:54:08	Ask21:54:08	Underlying	Strike price	Expiration date	Option type
1.320EUR	-7.69%	- Bid Size: -	- Ask Size: -	Vertex Pharmaceutica...	324.9958 USD	31/12/2078	Call

GlobeNewswire 13/08 Entrada Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire 09/08 ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire 07/08 Editas Medicine Announces Second Quarter 2024 Results and Business Updates

GlobeNewswire 05/08 Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire 05/08 CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Newsfile Corp 17/07 Analysts Hunt for Undervalued Biotech Stocks

Newsfile Corp 11/07 Biopharma Stocks Transformative Innovation for the Future of Health

GlobeNewswire 09/07 Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management

GlobeNewswire 09/07 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors

GlobeNewswire 28/06 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...

GlobeNewswire 10/06 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...

GlobeNewswire 29/05 CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire 23/05 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

GlobeNewswire 15/05 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 09/05 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

GlobeNewswire 08/05 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 08/05 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...

GlobeNewswire 08/05 Editas Medicine Announces First Quarter 2024 Results and Business Updates

GlobeNewswire 07/05 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 30/04 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...

GlobeNewswire 27/04 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN

GlobeNewswire 25/04 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 22/04 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...

GlobeNewswire 22/04 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...

GlobeNewswire 22/04 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN

UBS Knock-Out VRTX/ DE000UK2V6K0 /

If you wish to receive reply to your feedback, please provide your email address.